Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial
| Autor: | Robidoux, André, Tang, Gong, Rastogi, Priya, Geyer, Charles E, Jr, Azar, Catherine A, Atkins, James N, Fehrenbacher, Louis, Bear, Harry D, Baez-Diaz, Louis, Sarwar, Shakir, Margolese, Richard G, Farrar, William B, Brufsky, Adam M, Shibata, Henry R, Bandos, Hanna, Paik, Soonmyung, Costantino, Joseph P, Swain, Sandra M, Mamounas, Eleftherios P, Wolmark, Norman |
|---|---|
| Zdroj: | In Lancet Oncology November 2013 14(12):1183-1192 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|